248 related articles for article (PubMed ID: 15946754)
1. Further evidence of inflammation in chronic rheumatic valve disease (CRVD): high levels of advanced oxidation protein products (AOPP) and high sensitive C-reactive protein (hs-CRP).
Chiu-Braga YY; Hayashi SY; Schafranski M; Messias-Reason IJ
Int J Cardiol; 2006 May; 109(2):275-6. PubMed ID: 15946754
[TBL] [Abstract][Full Text] [Related]
2. Relationship between inflammation and atrial fibrillation in patients with isolated rheumatic mitral stenosis.
Selcuk MT; Selcuk H; Maden O; Temizhan A; Aksu T; Dogan M; Sasmaz A
J Heart Valve Dis; 2007 Sep; 16(5):468-74. PubMed ID: 17944117
[TBL] [Abstract][Full Text] [Related]
3. Contribution of selected serum inflammatory mediators to the progression of chronic rheumatic valve disease, subsequent valve calcification and NYHA functional class.
Davutoglu V; Celik A; Aksoy M
J Heart Valve Dis; 2005 Mar; 14(2):251-6. PubMed ID: 15792187
[TBL] [Abstract][Full Text] [Related]
4. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
[TBL] [Abstract][Full Text] [Related]
5. Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities.
Fialová L; Kalousová M; Soukupová J; Sulková S; Merta M; Jelínková E; Horejsí M; Srámek P; Malbohan I; Mikulíková L; Tesar V; Zima T
Kidney Blood Press Res; 2004; 27(2):88-95. PubMed ID: 14739577
[TBL] [Abstract][Full Text] [Related]
6. [The expression and clinical implication of advanced oxidized protein products in patients with multiple organ dysfunction syndrome].
Xiong Y; Tang H; Li X; Liang YB; Liao XX; Zhan H; Jing XL; Li YJ; Ma ZF
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Sep; 20(9):542-5. PubMed ID: 18786315
[TBL] [Abstract][Full Text] [Related]
7. Raised C-reactive protein levels in patients with recent onset type 1 diabetes.
Picardi A; Valorani MG; Vespasiani Gentilucci U; Manfrini S; Ciofini O; Cappa M; Guglielmi C; Pozzilli P;
Diabetes Metab Res Rev; 2007 Mar; 23(3):211-4. PubMed ID: 16832831
[TBL] [Abstract][Full Text] [Related]
8. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
[TBL] [Abstract][Full Text] [Related]
9. Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors.
Valli A; Suliman ME; Meert N; Vanholder R; Lindholm B; Stenvinkel P; Watanabe M; Barany P; Alvestrand A; Anderstam B
Clin Chim Acta; 2007 Apr; 379(1-2):87-94. PubMed ID: 17292872
[TBL] [Abstract][Full Text] [Related]
10. High-sensitivity C-reactive protein may be an indicator of the development of atherosclerosis in myocardial bridging.
Duygu H; Zoghi M; Nalbantgil S; Ozerkan F; Cakir C; Ertas F; Yuksek U; Akilli A; Akin M; Ergene O
Int J Cardiol; 2008 Feb; 124(2):267-70. PubMed ID: 17395309
[TBL] [Abstract][Full Text] [Related]
11. Obesity, and not obstructive sleep apnea, is responsible for increased serum hs-CRP levels in patients with sleep-disordered breathing in Delhi.
Sharma SK; Mishra HK; Sharma H; Goel A; Sreenivas V; Gulati V; Tahir M
Sleep Med; 2008 Jan; 9(2):149-56. PubMed ID: 17638590
[TBL] [Abstract][Full Text] [Related]
12. Association between C-reactive protein and clinical outcomes in peritoneal dialysis patients.
Avram MM; Fein PA; Paluch MM; Schloth T; Chattopadhyay J
Adv Perit Dial; 2005; 21():154-8. PubMed ID: 16686309
[TBL] [Abstract][Full Text] [Related]
13. Plasma pyridoxal 5'-phosphate and high-sensitivity C-reactive protein are independently associated with an increased risk of coronary artery disease.
Cheng CH; Lin PT; Liaw YP; Ho CC; Tsai TP; Chou MC; Huang YC
Nutrition; 2008 Mar; 24(3):239-44. PubMed ID: 18312786
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of high sensitive C-reactive protein in patients with chronic rheumatic valve disease: evidence of ongoing inflammation.
Gölbasi Z; Uçar O; Keles T; Sahin A; Cagli K; Camsari A; Diker E; Aydogdu S
Eur J Heart Fail; 2002 Oct; 4(5):593-5. PubMed ID: 12413502
[TBL] [Abstract][Full Text] [Related]
15. The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure.
Madsen T; Schmidt EB; Christensen JH
J Ren Nutr; 2007 Jul; 17(4):258-63. PubMed ID: 17586424
[TBL] [Abstract][Full Text] [Related]
16. Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation.
Hatzinikolaou-Kotsakou E; Tziakas D; Hotidis A; Stakos D; Floros D; Papanas N; Chalikias G; Maltezos E; Hatseras DI
Am J Cardiol; 2006 Mar; 97(5):659-61. PubMed ID: 16490433
[TBL] [Abstract][Full Text] [Related]
17. Advanced oxidation protein products (AOPP) and high-sensitive C-reactive protein (hs-CRP) in an "atheroma-free model": Down's syndrome.
Goi G; Baquero-Herrera C; Licastro F; Dogliotti G; Corsi MM
Int J Cardiol; 2006 Nov; 113(3):427-9. PubMed ID: 16343667
[TBL] [Abstract][Full Text] [Related]
18. A study of high-sensitivity C-reactive protein in bronchial asthma.
Sahoo RC; Acharya PR; Noushad TH; Anand R; Acharya VK; Sahu KR
Indian J Chest Dis Allied Sci; 2009; 51(4):213-6. PubMed ID: 20073372
[TBL] [Abstract][Full Text] [Related]
19. "Poor man's risk factor": correlation between high sensitivity C-reactive protein and socio-economic class in patients of acute coronary syndrome.
Sethi R; Puri A; Makhija A; Singhal A; Ahuja A; Mukerjee S; Dwivedi SK; Narain VS; Saran RK; Puri VK
Indian Heart J; 2008; 60(3):205-9. PubMed ID: 19240308
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of lipophilic antioxidant vitamins in acute ischemic stroke patients: correlation to inflammation markers and neurological deficits.
Chang CY; Chen JY; Ke D; Hu ML
Nutrition; 2005 Oct; 21(10):987-93. PubMed ID: 16157235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
